Skip to main content
. 2021 Nov 3;92(5):e2021291. doi: 10.23750/abm.v92i5.9866

Table 1.

Comparison of Demographic and Biochemical Characteristics between Groups

Quantitative variables Mean ± SD Group 1 (Normal Prolactin) (N=208) Group 2 (Macroprolactin) (N=72) Group 3 (Pituitary Adenoma) (N=33) Group 4 (Idiopathic Hyperprolactinemia) (N=17) P-value
Age(year) 25.51±13.25 23.49±4.91 24.94±3.71 24.24±3.23 0.6
BMI(Kg/m2) 25.36±3.82 24.25±6.21 30.59±31.40 28.60±17.70 0.1
FBS(mmol) 4.86±0.69 4.84±0.62 4.86±0.83 4.76±0.97 0.9
Insulin level mlU/ml 12.19±5.17 11.58±3.69 11.03±4.85 10.77±2.39 0.3
HOMA-IR 2.67±1.20 2.54±0.88 2.53±1.23 2.29±0.75 0.3
LH mlU/ml 8.63±3.74 7.02±3.35 7.49±3.54 7.01±3.79 0.01§
FSH mlU/ml 5.39±1.97 5.55±2 6.18±2.03 4.77±1.92 0.09
LH/FSH 1.82±1.51 1.39±0.77 1.37±1.43 1.29±0.69 0.02§
T-testosterone ng/ml 0.86±1.50 0.84±1.11 0.64±0.15 0.58±0.18 0.6
Prolactin ng/ml 16.93±4.81 41.56±4.61 59.19±8.56 44.56±8.85 0.001§
TSH mlU/ml 3.92±11.46 4.56±12.73 2.23±0.95 2.25±0.95 0.7
Estradiol pg/ml 38.84±30.60 43.73±21.04 49.06±19.31 50±57.3 0.01,0.04ᶲ

§Group 1 Vs. Group 2, 3, 4; ᶲ Group 1 Vs. Group 2, 3 (P=0.01), Group 1 Vs. Group 4 (P=0.04)

HHS Vulnerability Disclosure